Literature DB >> 26097203

Inside the 8p23.1 duplication syndrome; eight microduplications of likely or uncertain clinical significance.

John C K Barber1, Jill A Rosenfeld2, John M Graham3, Nancy Kramer3, Katherine L Lachlan4, Mark S Bateman5, Morag N Collinson5, Barbro Fossøy Stadheim6, Claire L S Turner7, Jacqueline N Gauthier8, Tyler E Reimschisel8, Athar M Qureshi9, Tabib A Dabir10, Mervyn W Humphreys11, Michael Marble12, Taosheng Huang13, Sarah J Beal5, Joanne Massiah5, Emma-Jane Taylor5, Sarah L Wynn14.   

Abstract

The 8p23.1 duplication syndrome (8p23.1 DS) is a recurrent genomic condition with an estimated prevalence of 1 in 58,000. The core 3.68 Mb duplication contains 32 genes of which five are currently candidates for the phenotypic features. Here we describe four patients and five families with eight microduplications of 8p23.1 ranging from 187 to 1082 kb in size and one atypical duplication of 4 Mb. These indicate that a minimal region of overlap (MRO) in medial 8p23.1 can give rise to features of 8p23.1 DS including developmental delay, dysmorphism, macrocephaly and otitis media, but not congenital heart disease (CHD). This MRO spans 776 kb (chr8:10,167,881-10,943,836 hg19) and contains SOX7 and seven of the other 32 core 8p23.1 DS genes. In centromeric 8p23.1, microduplications including GATA4 can give rise to non-syndromic CHD but the clinical significance of two smaller centromeric microduplications without GATA4 was uncertain due to severe neurological profiles not usually found in 8p23.1 DS. The clinical significance of three further 8p23.1 microduplications was uncertain due to additional genetic factors without which the probands might not have come to medical attention. Variable expressivity was indicated by the almost entirely unaffected parents in all five families and the mildly affected sibling in one. Intronic interruptions of six genes by microduplication breakpoint intervals had no apparent additional clinical consequences. Our results suggest that 8p23.1 DS is an oligogenetic condition largely caused by the duplication and interactions of the SOX7 and GATA4 transcription factors.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  8p23.1; DNA array; GATA4; SOX7; candidate genes; clinical significance; microduplication; variable penetrance

Mesh:

Substances:

Year:  2015        PMID: 26097203     DOI: 10.1002/ajmg.a.37120

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Neocentromeres to the Rescue of Acentric Chromosome Fragments.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-10-11

2.  Prenatal and postnatal diagnoses and phenotype of 8p23.3p22 duplication in one family.

Authors:  Panlai Shi; Conghui Wang; Yuting Zheng; Xiangdong Kong
Journal:  BMC Med Genomics       Date:  2021-03-23       Impact factor: 3.063

3.  Twenty-Five Novel Loci for Carotid Intima-Media Thickness: A Genome-Wide Association Study in >45 000 Individuals and Meta-Analysis of >100 000 Individuals.

Authors:  Ming Wai Yeung; Siqi Wang; Yordi J van de Vegte; Oleg Borisov; Jessica van Setten; Harold Snieder; Niek Verweij; M Abdullah Said; Pim van der Harst
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-12-02       Impact factor: 8.311

4.  De novo 8p21.3→ p23.3 Duplication With t(4;8)(q35;p21.3) Translocation Associated With Mental Retardation, Autism Spectrum Disorder, and Congenital Heart Defects: Case Report With Literature Review.

Authors:  Cristina Gug; Dorina Stoicanescu; Ioana Mozos; Laura Nussbaum; Mariana Cevei; Danae Stambouli; Anca Gabriela Pavel; Gabriela Doros
Journal:  Front Pediatr       Date:  2020-07-08       Impact factor: 3.418

5.  Connection between SOX7 Expression and Breast Cancer Prognosis.

Authors:  Chun-Xin Qin; Xiao-Qing Yang; Zhi-Yong Zhan
Journal:  Med Sci Monit       Date:  2020-04-02

6.  Characterization of Chromosomal Breakpoints in 12 Cases with 8p Rearrangements Defines a Continuum of Fragility of the Region.

Authors:  Serena Redaelli; Donatella Conconi; Elena Sala; Nicoletta Villa; Francesca Crosti; Gaia Roversi; Ilaria Catusi; Chiara Valtorta; Maria Paola Recalcati; Leda Dalprà; Marialuisa Lavitrano; Angela Bentivegna
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.